ESC 365 - Inhibiting chondroitin sulfate synthase 1 ameliorates hyperplastic arterial remodelling

ESC Professional Premium Access

Inhibiting chondroitin sulfate synthase 1 ameliorates hyperplastic arterial remodelling

Session: Novel mechanisms of atherosclerosis

Topic: Vascular Diseases: Fibrosis

Speaker: Doctor D. Liao (Singapore, SG) Mr W. Chng (SG)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speakers

Doctor Dan Liao

National University of Singapore, Singapore (Singapore)

0 follower

Mr Wei Seng Chng

(Singapore)

1 presentation

0 follower

7 more presentations in this session

A novel VCP modulator, KUS121, attenuates atherosclerosis progression by maintaining intracellular ATP and mitigating ER stress in endothelial cells

Speaker: Doctor O. Baba (Kyoto, JP)

Biomimetic porphyrin-lipid nanoparticles - novel nanoscale theranostics for multimodal imaging and therapy in atherosclerotic cardiovascular disease

Speaker: Doctor V. Nankivell (Adelaide, AU)

Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesis

Speaker: Doctor M. Drozd (Leeds, GB)

Profiling the L-arginine/arginase 1 metabolism in early and advanced atherosclerosis

Speaker: Mrs Y. Wu (Munich, DE)

Myeloid Tgfbr1/2-deficiency leads to a pro-atherogenic environment in ApoE-/- mice

Speaker: Doctor V. Bazioti (Munich, DE)

Access the full session

Novel mechanisms of atherosclerosis

Speakers: Doctor D. Liao, Mr W. Chng, Doctor O. Baba, Doctor V. Nankivell, Doctor M. Drozd...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources